Catalyst Wire Dossier Catalyst Wire Dossier

Buprenorphine Transdermal System (BTDS)

buprenorphine · Purdue Pharma LP
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Buprenorphine Transdermal System (BTDS), covering 2010-10-15 to 2011-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods [Phase 1]

See pricing